Physician profile
Bruce E Johnson
NPI 1619076643
$4,654.85
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $1,349 · 2021: $884.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $898.25 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $840.91 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $351.64 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $288.36 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $236.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.26 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $201.34 | 2020-2021 | |
| Advanced Respiratory, INC | $162.66 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $160.30 | 2019-2021 | |
| Genentech USA, INC. | $155.91 | 2019 | |
| Insmed, INC. | $143.10 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $95.66 | 2019-2021 | |
| Genzyme Corporation | $94.16 | 2019-2021 | |
| Grifols USA, LLC | $83.75 | 2019-2020 | |
| Resmed Corp | $82.02 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $81.68 | 2019 | |
| Mylan Specialty L.P. | $63.66 | 2019-2020 | |
| Philips North America LLC | $59.76 | 2019 | |
| Pfizer INC. | $55.54 | 2019 | |
| Harmony Biosciences LLC | $49.03 | 2020 | |
| Janssen Pharmaceuticals, INC | $42.41 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.50 | 2019 | |
| Gilead Sciences, INC. | $33.66 | 2019 | |
| Electromed, INC. | $26.06 | 2019-2021 | |
| Circassia INC. | $25.34 | 2019 | |
| Pulmonx Corporation | $24.66 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $23.11 | 2021 | |
| Nabriva Therapeutics, Plc | $20.72 | 2021 | |
| Shire North American Group INC | $18.73 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.73 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.57 | 2019 | |
| Boston Scientific Corporation | $15.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.44 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.